Document Detail


Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results. A 35-year experience.
MedLine Citation:
PMID:  23208526     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
To evaluate the long-term oncologic results of supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) for laryngeal cancer. A 35-year retrospective study concerning 291 patients treated by supracricoid laryngectomy with CHEP for laryngeal cancer was performed. The following postoperative data were studied: recurrence rates (lymph node and laryngeal), distant metastases and second cancer. The mortality rate and overall survival were estimated by the Kaplan-Meier method. The postoperative mortality was 1.03 %. 23 patients were lost to follow-up. The 3-year survival rate was 84 % and the 5-year survival rate was 80 %. 12 patients developed distant metastasis. 31 patients developed a second cancer. The local (laryngeal) control rate was 93.94 % and the regional (cervical lymph node) control rate was 92.05 %. In multivariate analysis, the occurrence of a second non-ENT cancer and metastasis as well as margins involvement were reliable to mortality. Supracricoid laryngectomy with CHEP appears to be associated with very good long-term oncologic results and still has a place in the management of T1, T2 and selected T3 glottic cancers.
Authors:
C Page; G Mortuaire; F Mouawad; O Ganry; J Darras; X Pasquesoone; D Chevalier
Related Documents :
24189076 - Electricians' chrysotile asbestos exposure from electrical products and risks of mesoth...
24389306 - Mortality, cancer, and comorbidities associated with chronic pancreatitis-a danish nati...
25040886 - Prediagnostic serum levels of inflammatory biomarkers are correlated with future develo...
23771716 - Moderate-to-vigorous intensity physical activity across the life course and risk of pre...
18316586 - Cdc25a phosphatase: a rate-limiting oncogene that determines genomic stability.
8744796 - Racial comparison of p53 alterations in breast cancer: difference in prognostic value.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-4
Journal Detail:
Title:  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery     Volume:  -     ISSN:  1434-4726     ISO Abbreviation:  Eur Arch Otorhinolaryngol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002937     Medline TA:  Eur Arch Otorhinolaryngol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
ENT and Head and Neck Surgery Department, University Hospital of Amiens, Amiens, France, cyril_page@yahoo.fr.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of high dose intravenous vitamin C on idiopathic sudden sensorineural hearing loss: a prospec...
Next Document:  A novel technique of otic barotrauma management using modified intravenous cannulae.